TY  - JOUR
AU  - Gutiérrez, Lourdes
AU  - Royuela, Ana
AU  - Carcereny, Enric
AU  - López-Castro, Rafael
AU  - Rodríguez-Abreu, Delvys
AU  - Massuti, Bartomeu
AU  - González-Larriba, José Luis
AU  - García-Campelo, Rosario
AU  - Bosch-Barrera, Joaquim
AU  - Guirado, María
AU  - Camps, Carlos
AU  - Dómine, Manuel
AU  - Bernabé, Reyes
AU  - Casal, Joaquín
AU  - Oramas, Juana
AU  - Ortega, Ana Laura
AU  - Sala, Mª Angeles
AU  - Padilla, Airam
AU  - Aguiar, David
AU  - Juan-Vidal, Oscar
AU  - Blanco, Remei
AU  - Del Barco, Edel
AU  - Martínez-Banaclocha, Natividad
AU  - Benítez, Gretel
AU  - de Vega, Blanca
AU  - Hernández, Ainhoa
AU  - Saigi, Maria
AU  - Franco, Fernando
AU  - Provencio, Mariano
PY  - 2021
DO  - 10.1186/s12885-021-08713-8
UR  - http://hdl.handle.net/10668/18484
T2  - BMC cancer
AB  - There is a lack of useful diagnostic tools to identify EGFR mutated NSCLC patients with long-term survival. This study develops a prognostic model using real world data to assist clinicians to predict survival beyond 24 months. EGFR mutated stage IIIB...
LA  - en
KW  - EGFR
KW  - Long survival
KW  - Nomogram
KW  - Non-small cell lung cancer
KW  - Predictive modeling
KW  - Aged
KW  - Biomarkers, Tumor
KW  - Cancer Survivors
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Chemoradiotherapy
KW  - ErbB Receptors
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Models, Statistical
KW  - Mutation
KW  - Nomograms
KW  - Prognosis
KW  - Retrospective Studies
KW  - Survival Rate
TI  - Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.
TY  - research article
VL  - 21
ER  -